000017617 000__ 01740cam\a2200493\i\4500
000017617 001__ 17617
000017617 003__ SzGeWIPO
000017617 005__ 20210318104656.0
000017617 008__ 840601s1984\\\\nyua\\\\rb\\\\001\0\eng\\
000017617 020__ $$a9780080316208
000017617 020__ $$z0080316204
000017617 035__ $$a(wipo)(CD )84/1592
000017617 035__ $$a(OCoLC)10850568
000017617 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000017617 041__ $$aeng
000017617 043__ $$an-us---
000017617 050_4 $$aHD9999.B443$$bU62 1984
000017617 050_4 $$aHD9999B443$$bU62
000017617 08204 $$a338.4766060973$$219
000017617 084__ $$aG 25 OTA.C
000017617 1102_ $$aOffice Of Technology Assessment (OTA),$$eissuing body.
000017617 24510 $$aCommercial biotechnology :$$ban international analysis /$$cOffice of Technology Assessment, Congress of the United States.
000017617 264_1 $$aNew York :$$bPergamon Press,$$c1984.
000017617 300__ $$ax, 612 pages :$$billustrations ;$$c29 cm
000017617 336__ $$atext$$btxt$$2rdacontent
000017617 337__ $$aunmediated$$bn$$2rdamedia
000017617 338__ $$avolume$$bnc$$2rdacarrier
000017617 504__ $$aIncludes bibliographical references and index.
000017617 650_0 $$aBiotechnology industries$$zUnited States.
000017617 650_0 $$aCompetition, International$$zUnited States.
000017617 650_0 $$aBiotechnology industries.
000017617 650_0 $$aCompetition, International.
000017617 650_0 $$aPatents$$zUnited States.
000017617 650_4 $$aPATENTS : PATENTABILITY : PHARMACEUTICAL PRODUCTS, MEDICINE, BIOLOGY
000017617 651_0 $$aUnited States$$xCommerce$$xLaw and legislation.
000017617 7102_ $$aUnited States.
000017617 7102_ $$aUnited States.$$bCongress.
000017617 7102_ $$aUSA.$$bOffice Of Technology Assessment.
000017617 7102_ $$aUSA.$$bCongress.
000017617 7102_ $$aétats-Unis.$$bCongress.
000017617 903__ $$v1
000017617 942__ $$cMON$$2ddc
000017617 952__ $$w2006-11-03$$p1984-1592$$r20.00$$u22482$$bMAIN$$10$$kG 25 OTA.C$$v1991-06-24$$ztagged$$71
000017617 980__ $$aBIB
000017617 999__ $$c18591$$d18591